Related Experiment Video
Updated: May 15, 2025
Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT
Published on: January 22, 2018
Advances in nanomedicine and delivery systems for gastric cancer research
Sizhe Wang1, Jilei Li2, Zhenyu Zhang1
1Henan University of Chinese Medicine(The Second Clinical Medical College of Henan University of Chinese Medicine), Zhengzhou, Henan, China.
Abstract:
The early diagnosis rate of gastric cancer is low, and most patients are already at an advanced stage by the time they are diagnosed, posing significant challenges for treatment and exhibiting high recurrence rates, which notably diminish patients' survival time and quality of life. Therefore, there is an urgent need to identify methods that can enhance treatment efficacy. Nanomedicine, distinguished by its small size, high targeting specificity, and strong biological compatibility, is particularly well-suited to address the toxic side effects associated with current diagnostic and therapeutic approaches for gastric cancer. Consequently, the application of nanomedicine and delivery systems in the diagnosis and treatment of gastric cancer has garnered increasing interest from researchers. This review provides an overview of recent advancements in the use of nanomaterials as drugs or drug delivery systems in gastric cancer research, encompassing their applications in diagnosis, chemotherapy, radiotherapy, surgery, and phototherapy, and explores the promising prospects of nanomedicine in the treatment of gastric cancer.
Insights
Nanomedicine offers a promising approach to improve gastric cancer treatment by enhancing drug delivery and reducing side effects. This review explores nanomaterials for diagnosing and treating gastric cancer, from chemotherapy to phototherapy.
Area of Science:
- Oncology
- Nanotechnology
- Biomedical Engineering
Background:
- Gastric cancer diagnosis often occurs at advanced stages, leading to poor treatment outcomes and high recurrence rates.
- Current treatments for gastric cancer face challenges including significant toxic side effects and limited efficacy.
- There is a critical need for innovative strategies to improve gastric cancer treatment efficacy and patient quality of life.
Purpose of the Study:
- To review recent advancements in nanomedicine for gastric cancer diagnosis and treatment.
- To explore the application of nanomaterials in various therapeutic modalities for gastric cancer.
- To discuss the future prospects of nanomedicine in managing gastric cancer.
Main Methods:
- Literature review of recent research on nanomedicine applications in gastric cancer.
- Analysis of nanomaterials used in diagnosis, chemotherapy, radiotherapy, surgery, and phototherapy.
- Synthesis of findings on the efficacy and challenges of nanomedicine-based gastric cancer therapies.
Main Results:
- Nanomaterials show potential for targeted drug delivery, improving therapeutic efficacy in gastric cancer.
- Nanomedicine applications span diagnosis, chemotherapy, radiotherapy, surgical enhancement, and phototherapy for gastric cancer.
- The unique properties of nanomaterials offer advantages in overcoming limitations of conventional gastric cancer treatments.
Conclusions:
- Nanomedicine presents a highly promising avenue for advancing gastric cancer care due to its specificity and biocompatibility.
- Further research into nanomedicine delivery systems can significantly enhance treatment outcomes and patient survival in gastric cancer.
- The integration of nanomedicine holds substantial potential for revolutionizing the diagnosis and treatment landscape of gastric cancer.
